CareFusion gets delisting warning from NYSE

CareFusion ($CFN) has further delayed filing its fiscal 2012 results, and the New York Stock Exchange (NYSE) is warning the company it will wind up getting delisted if it doesn't file a 10-K within 6 months.

In August, CareFusion got a 15-day extension on the filing from the SEC, looking to consult with the agency on its accounting methods. That window closed Sept. 13, resulting in the NYSE warning, but CareFusion said in a release that the notice is routine in cases of delayed filing.

"The consultation process with the SEC is ongoing," the company said in a statement. "Once this process is complete, the company will assess any impact on its financial statements and file its Form 10-K as soon as practicable." In the meantime, its NYSE listing will be accompanied by an "LF," indicating that the firm is late to file its results.

CareFusion has been beset by Class I recalls of late, recording four in the fourth quarter alone, contributing to a $7 million charge. However, the company still recorded a 29% net profit increase on the quarter, bringing in $110 million. Revenue jumped 3% $968 million, and CareFusion slashed its selling and administrative expenses by 10%.

- read CareFusion's statement

Suggested Articles

The clinical testing giant LabCorp will now begin rolling out a blood test for lung cancer developed by Resolution Bioscience.

Cognoa aims to equip pediatricians with an AI-powered app that can spot the signs of autism, allowing them to diagnose in the doctor's office.

Longitude Capital invests in what its founders call “transformative healthcare companies," working in areas they hope will increase quality of life.